Rui Deng

1.1k total citations · 1 hit paper
33 papers, 826 citations indexed

About

Rui Deng is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Rui Deng has authored 33 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Molecular Biology and 7 papers in Hepatology. Recurrent topics in Rui Deng's work include Hepatitis B Virus Studies (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (6 papers). Rui Deng is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (6 papers). Rui Deng collaborates with scholars based in China, United States and Hong Kong. Rui Deng's co-authors include Shihong Nie, Ling Li, Yuquan Wei, Qinjie Wu, Xun Jin, Changyang Gong, Lu Sun, Ning Wang, Jinyuan Zhang and Jian-Ting Chen and has published in prestigious journals such as Biomaterials, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Rui Deng

33 papers receiving 816 citations

Hit Papers

Biodegradable and injectable in situ cross-linking chitos... 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for postoperative adhesion prevention
    2014 394 citations Ling Li, Ning Wang et al. Biomaterials profile →

Peers

Rui Deng
Lichao Yao China
Yeonsil Yu South Korea
Changjiang Yu China
Alain da Silva Morais Portugal
Qing He China
Lingjie Li China
Zhihe Liu China
Yi Liang China
Qiaoli Gu China
Xiaoming Shuai China
Lichao Yao China
Rui Deng
Citations per year, relative to Rui Deng Rui Deng (= 1×) peers Lichao Yao

Countries citing papers authored by Rui Deng

Since Specialization
Citations

This map shows the geographic impact of Rui Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Deng more than expected).

Fields of papers citing papers by Rui Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Deng. The network helps show where Rui Deng may publish in the future.

Co-authorship network of co-authors of Rui Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Deng. A scholar is included among the top collaborators of Rui Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Deng. Rui Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Kaifeng, Zhixian Lan, Rong Fan, et al.. (2025). Long-chain acylcarnitine deficiency promotes hepatocarcinogenesis. Acta Pharmaceutica Sinica B. 15(3). 1383–1396. 1 indexed citations
2.
Zhao, Zhou, Zhixian Lan, Hongyan Liang, et al.. (2025). Reduction of Bacteroides fragilis in Gut Microbiome of Chronic Hepatitis B Patients Promotes Liver Injury. Journal of Medical Virology. 97(5). e70395–e70395. 2 indexed citations
3.
Luo, Dan, Rong‐Hua Luo, Weilin Wang, et al.. (2024). Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1. Bioorganic & Medicinal Chemistry Letters. 111. 129880–129880. 9 indexed citations
4.
Li, Wanying, Rui Deng, Bin Zhou, et al.. (2024). Serum hepatitis B virus spliced RNA proportion increases with liver disease progression in patients with chronic hepatitis B. Journal of Medical Virology. 96(2). e29400–e29400. 4 indexed citations
5.
Shen, Sheng, Dawei Cai, Hongyan Liang, et al.. (2024). NEDD4 family ubiquitin ligase AIP4 interacts with Alix to enable HBV naked capsid egress in an Alix ubiquitination-independent manner. PLoS Pathogens. 20(9). e1012485–e1012485. 3 indexed citations
6.
Zeng, Min, Xiaoyun Zhang, L. He, et al.. (2023). Human papillomavirus infections among women with cervical lesions and cervical cancer in Yueyang, China: a cross-sectional study of 3674 women from 2019 to 2022. Virology Journal. 20(1). 254–254. 4 indexed citations
7.
Li, Hongxing, Peng Cheng, Rui Deng, et al.. (2023). Clostridium butyricum and Clostridium tyrobutyricum : angel or devil for necrotizing enterocolitis?. mSystems. 8(6). e0073223–e0073223. 3 indexed citations
8.
Deng, Rui, Shi Liu, Sheng Shen, Haitao Guo, & Jian Sun. (2022). Circulating HBV RNA: From biology to clinical applications. Hepatology. 76(5). 1520–1530. 29 indexed citations
9.
Ma, Xinyu, Hongjia Zhang, Shirui Wang, et al.. (2022). Recent Advances in the Discovery and Development of Anti-HIV Natural Products. The American Journal of Chinese Medicine. 50(5). 1173–1196. 3 indexed citations
10.
Peng, Cheng, Peiliang Shen, Yunlong Shan, et al.. (2021). Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy. Frontiers in Cell and Developmental Biology. 9. 626045–626045. 11 indexed citations
11.
Liu, Shi, Rui Deng, Rong Fan, et al.. (2021). Methodology-dependent performance of serum HBV RNA in predicting treatment outcomes in chronic hepatitis B patients. Antiviral Research. 189. 105037–105037. 11 indexed citations
12.
Liu, Shi, Zhihong Liu, Wanying Li, et al.. (2020). Factors associated with the biphasic kinetics of serum HBV RNA in patients with HBeAg‐positive chronic hepatitis B treated with nucleos(t)ide analogues. Alimentary Pharmacology & Therapeutics. 52(4). 692–700. 17 indexed citations
13.
Li, Wanying, Rui Deng, Shi Liu, Kaifeng Wang, & Jian Sun. (2020). Hepatitis B virus‐related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non‐viral risk factors. Liver International. 40(10). 2316–2325. 23 indexed citations
14.
Liu, Shi, Rui Deng, Bin Zhou, & Jian Sun. (2020). Is the World Health Organization Hepatitis B Virus (HBV) DNA Standard Appropriate for Standardizing Serum HBV RNA Assays?. Clinical Infectious Diseases. 73(9). e2821–e2823. 1 indexed citations
15.
Zhang, Ying, et al.. (2018). Microarray Expression Profiles of lncRNAs and mRNAs in Postoperative Cognitive Dysfunction. Frontiers in Neuroscience. 12. 694–694. 23 indexed citations
16.
Deng, Rui, Hai Yi, Yilan Liu, et al.. (2015). Enhanced antitumor effect of combining chemotherapy with Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes in mice with EBV-related non-Hodgkin's lymphoma. Molecular and Clinical Oncology. 3(6). 1233–1238. 1 indexed citations
17.
18.
Tao, Kaixiong, Weilong Chang, Ende Zhao, et al.. (2015). Clinicopathologic Features of Gastric Schwannoma. Medicine. 94(45). e1970–e1970. 35 indexed citations
19.
Li, Ling, Ning Wang, Xun Jin, et al.. (2014). Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for postoperative adhesion prevention. Biomaterials. 35(12). 3903–3917. 394 indexed citations breakdown →
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lichao Yao Breakdown of academic impact, for papers by Yeonsil Yu Breakdown of academic impact, for papers by Changjiang Yu Breakdown of academic impact, for papers by Alain da Silva Morais Breakdown of academic impact, for papers by Qing He Breakdown of academic impact, for papers by Lingjie Li Breakdown of academic impact, for papers by Zhihe Liu Breakdown of academic impact, for papers by Yi Liang Breakdown of academic impact, for papers by Qiaoli Gu Breakdown of academic impact, for papers by Xiaoming Shuai
Rankless by CCL
2026